Refine
Document type
- Bachelor Thesis (2)
Language
- English (2) (remove)
Has full text
- No (2)
Is part of the Bibliography
- No (2)
Keywords
- Sales (2) (remove)
Course of studies
- IBM - International Business Management (2) (remove)
While Africa presents huge markets for foreign software, sales in these markets have been decreasing over the years. This downward movement in sales can be attributed to the challenges software companies are facing in these markets.
Using the case of TeamViewer GmbH in South Africa and Nigeria, this paper seeks to examine these challenges and give possible recommendations on how to improve sale. It also would analyze the opportunities present in these markets for foreign software.
Through an interview with customers and re-sellers in the South African and Nigerian markets, we uncover that, high prices, competition, unawareness of subscription, to name a few, are some of the challenges resulting in poor sales. Also, using the political, economical, social, technological, legal and environmental (PESTLE) model of analysis, an overview of the socio-economic and political situation in these markets were examined. The findings from this paper would serve as a spring board for further research on this topic.
The B. Braun Aesculap AG division “Degenerative Spinal Disorders” will be launching a new Spinal System mid 2017. A Spinal System is a combination of implants and instruments used to treat spinal disorders caused by deformity, tumors, trauma or via degenerative conditions.
The current industry standard is that manufacturers sell the implants necessary for these surgeries in non-sterile packs, which require sterilization by the client organizations. This is different in other orthopedic sectors such as hip or knee, where the use of sterile packed implants is the industry benchmark. As this is not the standard case for spinal surgery so far, all processes within the majority of client organizations are accustomed to using non-sterile packed spinal implants in their operating room processes and logistics.
The new Spinal System, being offered by Aesculap AG in the near future, is challenging this status quo, as it will be offering a system solution in which the implants will be sold in sterile packaging.
This new business model entails changes in the processes within the manufacturing and client organization. These changes need to be implemented and communicated correctly.
In this thesis both business models based on sterile and non-sterile packed implants and their respective processes are compared. Strategic and operative relevant aspects are analyzed to define strategic criteria necessary to appropriately implement and communicate the new system.